Blog
RSS FeedPosted by Michael Wonder on 17 Jan 2020
Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation
16 January 2020 - A Republican member of the Federal Trade Commission on Thursday expressed support for allowing Medicare to ...
Posted by Michael Wonder on 17 Jan 2020
Pricing of pharmaceuticals is becoming a major challenge for health systems
13 January 2020 - Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable. ...
Posted by Michael Wonder on 17 Jan 2020
Defining the concept of fair pricing for medicines
13 January 2020 - Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers. ...
Posted by Michael Wonder on 17 Jan 2020
BioMarin explores pricing experimental gene therapy at $2 million to $3 million
16 January 2020 - Valrox would be first gene therapy approved in U.S. for inherited type of haemophilia. ...
Posted by Michael Wonder on 16 Jan 2020
EQRX wants to make high-end medicines less costly
17 January 2020 - A Boston-based biotech startup thinks it has found a lucrative third way between high-margin branded drugs and ...
Posted by Michael Wonder on 16 Jan 2020
Pharma execs pitch ideas at JPM20 to lower drug costs. None of them include dropping their own prices.
16 January 2020 - CEOs from the world’s largest pharmaceutical companies pitched ideas for lowering drug prices at the J.P. Morgan ...
Posted by Michael Wonder on 16 Jan 2020
U.S. targets drug pricing, no-poach deals for anti-trust action in 2020
15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...
Posted by Michael Wonder on 16 Jan 2020
Prices of MS medications keep soaring
15 January 2020 - The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release ...
Posted by Michael Wonder on 15 Jan 2020
Democrats zero in on high drug prices in Iowa debate
14 January 2020 - Until Tuesday, nearly every single Democratic primary debate has focused on the same health care issue: ...
Posted by Michael Wonder on 14 Jan 2020
Roche aims to 'underwhelm' on SMA drug price to challenge rivals
14 January 2020 - Swiss drug maker Roche plans to price its oral spinal muscular atrophy drug risdiplam aggressively to challenge ...
Posted by Michael Wonder on 13 Jan 2020
High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’
13 January 2020 - The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” ...
Posted by Michael Wonder on 13 Jan 2020
Drug makers test new ways to pay for six figure treatments
13 January 2020 - Public pressure, insurer pushback and better data are driving drug companies to tinker with how they get ...
Posted by Michael Wonder on 12 Jan 2020
The Tories must learn from the Orkambi victory and keep drug-pricing off the table
12 January 2020 - To match its rhetoric on the NHS, the government has to legally commit to preventing drug-pricing being ...
Posted by Michael Wonder on 12 Jan 2020
Start-up proposes ‘third way’ to cut US drug prices
12 January 2020 - Alexis Borisy secures $200 million funding for venture aiming to use ‘fast follow’ treatments. ...
Posted by Michael Wonder on 10 Jan 2020
Lies, damn lies, and drug price increases
9 January 2020 - As each new year begins, drug manufacturers announce their changes to the list price of drugs. ...